MAPT and Alzheimer disease: This hypothesis hasimportant therapeutic implications as recent developments in Alzheimer disease (AD)therapeutics, such as anti-β-amyloid antibodies, inhibitors of β-secretase or γ-secretase activity, or other amyloid- or tau-targetedtherapies50,51 may have potential roles in themanagement of TBI.1